Trials / Sponsors / Angitia Biopharmaceuticals
Angitia Biopharmaceuticals
Industry · 4 registered clinical trials.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Active Not Recruiting | A Trial Evaluating Efficacy of AGA2118 in PostMenopausal Women wIth Low Bone MasS (ARTEMIS) Postmenopausal Osteoporosis | Phase 2 | 2024-10-31 |
| Active Not Recruiting | A Phase 3 Study of AGA111 in Patients With Degenerative Disc Disease Undergoing Lumbar Interbody Fusion Degenerative Disc Disease | Phase 3 | 2023-12-08 |
| Completed | A First-in-Human Study Evaluating AGA2118 in Men and Postmenopausal Women Osteoporosis | Phase 1 | 2022-06-28 |
| Completed | A Phase I/II Study of AGA111 for Lumbar Interbody Fusion in Patients With Degenerative Disc Disease Degenerative Disc Disease | Phase 1 / Phase 2 | 2020-12-01 |